"Drug Evaluation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.
| Descriptor ID |
D004341
|
| MeSH Number(s) |
E05.337.425
|
| Concept/Terms |
Drug Evaluation- Drug Evaluation
- Drug Evaluations
- Evaluation, Drug
- Evaluations, Drug
- Evaluation Studies, Drug
- Drug Evaluation Studies
- Drug Evaluation Study
- Evaluation Study, Drug
- Studies, Drug Evaluation
- Study, Drug Evaluation
|
Below are MeSH descriptors whose meaning is more general than "Drug Evaluation".
Below are MeSH descriptors whose meaning is more specific than "Drug Evaluation".
This graph shows the total number of publications written about "Drug Evaluation" by people in this website by year, and whether "Drug Evaluation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 2 | 8 | 10 |
| 2019 | 0 | 3 | 3 |
| 2020 | 0 | 5 | 5 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Evaluation" by people in Profiles.
-
Criticism of methods used in medication Y-site mixing study. Am J Health Syst Pharm. 2021 08 30; 78(17):1553-1554.
-
Validity of methods used in medication Y-site mixing study. Am J Health Syst Pharm. 2021 08 30; 78(17):1554-1555.
-
Biases in Evaluating the Safety and Effectiveness of Drugs for the Treatment of COVID-19: Designing Real-World Evidence Studies. Am J Epidemiol. 2021 08 01; 190(8):1452-1456.
-
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations. Front Immunol. 2021; 12:669339.
-
Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation. Virol Sin. 2021 Oct; 36(5):890-900.
-
COVID-19 Vaccine: Development, Testing, and Distribution. Clin Nurse Spec. 2021 Mar-Apr 01; 35(2):62-64.
-
SARS-CoV-2: vaccines in the pandemic era. Mil Med Res. 2021 01 06; 8(1):1.
-
Audio Interview: An Update from Operation Warp Speed. N Engl J Med. 2020 Nov 12; 383(20):e127.
-
Learning from the past: development of safe and effective COVID-19 vaccines. Nat Rev Microbiol. 2021 03; 19(3):211-219.
-
Drug evaluation and pharmaceutical care in a critically ill COVID-19 patient. Int J Clin Pharmacol Ther. 2020 Oct; 58(10):568-574.